Assignee
PROTEOSYS AG
DE8 patents
Top patents by PatentIndex Score
US7732148B2Jun 8, 2010
Annexin A3 for prostate cancer diagnosis
PROTEOSYS AG10 citations82
US8039464B2Oct 18, 2011
Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases
PROTEOSYS AG5 citations60
US8012697B2Sep 6, 2011
Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma
PROTEOSYS AG3 citations60
US7538197B2May 26, 2009
Use of neuregulin-β as an indicator and/or target
PROTEOSYS AG2 citations60
US8377648B2Feb 19, 2013
Autoimmune regulation of prostate cancer by annexin A3
PROTEOSYS AG0 citations49
US7998970B2Aug 16, 2011
Use of finasteride, dutasteride and related compounds for the prevention or treatment of neurologically-associated disorders
PROTEOSYS AG1 citations48
US7824923B2Nov 2, 2010
Neuregulin-β isoforms associated with neuronal processes
PROTEOSYS AG0 citations39
US7759068B2Jul 20, 2010
Use of substances for treating tumors
PROTEOSYS AG0 citations39